5 research outputs found
Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab
Get PDFMaculopapular cutaneous mastocytosis (MPCM),
formerly telangiectasia macularis eruptiva perstans
(TMEP), is an uncommon form of cutaneous mastocytosis
first described on 1930 (1). It is more frequent
in adults, and early diagnosis is crucial since it has
been reported to be associated with serious underlying
systemic disorders, such as myeloproliferative
diseases and severe manifestations like anaphylaxis
(2,3). Treatment of MPCM depends on the presence of
systemic involvement and/or the clinical symptoms
of the disease itsel
Maculopapular Cutaneous Mastocytosis Successfully Treated with Omalizumab
Get PDFMaculopapular cutaneous mastocytosis (MPCM),
formerly telangiectasia macularis eruptiva perstans
(TMEP), is an uncommon form of cutaneous mastocytosis
first described on 1930 (1). It is more frequent
in adults, and early diagnosis is crucial since it has
been reported to be associated with serious underlying
systemic disorders, such as myeloproliferative
diseases and severe manifestations like anaphylaxis
(2,3). Treatment of MPCM depends on the presence of
systemic involvement and/or the clinical symptoms
of the disease itsel
